• General Information
  • Organism: Bunyaviridae virus
  • Transmission: inhalation of aerosols contaminated with rodent urine or feces.
  • Seen in the southwestern United States, South and Central America
  • Death occurs from decreased cardiac output and circulatory failure.
• Clinical Presentation
  • Initial symptoms are nonspecific and occur 1-5 weeks after exposure: fever, malaise, myalgia, and GI upset
    • Can progress to fulminant ARDS-like picture in previously health young patients.
  • Signs NOT consistent with HPS: rash, hemorrhage, petechiae, peripheral or periorbital edema.
• Diagnosis
  • The diagnosis must initially be made clinically.
  • Lab tests may reveal nonspecific findings of thrombocytopenia, atypical lympthocytes with bandemia, hemoconcentration, and renal failure.
  • Chest film will demonstrate bilateral interstitial infiltrates.
  • Serology (ELISA) available through the CDC.
• Treatment
  • There is no specific therapy for hantavirus infection; Treatment is primarily supportive, with attention to respiratory status and oxygenation.

University of Maryland Section for Global Emergency Health

Author: Andi Tenner

References

Center for Disease Control. (2012). Hantavirus.  Retrieved September 3, 2012, from http://www.cdc.gov/hantavirus/index.html

 

Berger, S. A., Calisher, C. H., and Keystone, J. H., (2003).  Exotic Viral Disease: A Global Guide. Hamilton, Ontario: BC Decker.